A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)


October 1, 2011

Clinical trial

Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.

Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG.

Ophthalmology. 2011 Oct;118(10):2041-9.
Full text | Metrics.

June 1, 2010

Clinical trial

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY.

Ophthalmology. 2010 Jun;117(6):1124-1133.e1.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive